| 产品详情 |
| Edit |   |
|---|
| Product Name | BCRP Inhibitor IV, YHO-13351 |
|---|
| Description | Purity ~97% (HPLC). An in vivo bioavailable (~87%; t1/2 100mg/ml) diethylaminoacetate prodrug of YHO-13177 that reverses BCRP-mediated irinotecan resistance in P388/BCRP and HCT116/BCRP xenograft mouse models, and suppresses tumor growth and significantly enhances the survival (100 or 200mg/kg, i.p.). Formula: C26H33N3O4S · CH3SO3H Molecular Weight: 579.7 Solubility: H2O (25mg/ml) |
|---|
| Size | 25mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | BCRP Inhibitor IV, YHO-13351 (Diethylaminoacetic Acid, 1-(5-((Z)-2-cyano-2- (3,4-dimethoxyphenyl)vinyl)thiophen-2-yl)piperidin-4-yl ester, Methanesulfonate) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217212 |
|---|
| Price | |
|---|
| Order / More Info | BCRP Inhibitor IV, YHO-13351 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|